Publication

Article

BioPharm International

BioPharm International-09-15-2019
Volume2019 eBook
Issue 3
Pages: 42

Regulatory and Standard Setting Organizations

Connect with pharmaceutical and healthcare regulatory authorities around the world via this directory.

Connect with pharmaceutical and healthcare regulatory authorities around the world via this directory.

View this resource in BioPharm International’s September 2019 Regulatory Sourcebook.

 

 

 

Articles in this issue
BPebook0919_PharmacopeiaCompendia_Harmonization_225.jpg
Global Pharmacopoeia Standards: Why Harmonization is Needed (eBook)
PBPebook0919_PharmacopeiaCompendia_ProblemStatement_225.jpg
Why Pharmacopoeia Compliance Is Difficult (eBook)
BPebook0919_PharmacopeiaCompendia_WhyNecessary_225.jpg
Why Pharmacopoeia Compliance Is Necessary (eBook)
BPebook0919_GuidanceUpdate_225.jpg
What’s New in Regulations and Compliance
BPebook0919_regulatoryUpdate_peters_225.jpg
Quality Culture Drives Patient Confidence in Drug Products
BPeBook0919_Regulatory_Biosimilars_125.jpg
Biosimilar Quality Requirements

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!
Related Videos
Behind the Headlines, Episode 23: Patent Cliff Deals, Tariff Pressures, and the In Vivo Cell Therapy Bet
Related Content
Document Review and Quality Control Concept. Document with a checkmark, quality assurance, and process control. auditing, compliance, verification, data inspection, and business workflow management. | Image Credit: © Supatman - stock.adobe.com
August 28th 2025

A Novel, Enhanced, and Sustainable Approach to Audit Trail Review

Diana Russo
Human eye close-up in black and white. Extended pupil | Image Credit: © Annashou - stock.adobe.com
August 28th 2025

VeonGen’s Stargardt Disease Gene Therapy Gets FDA RMAT Status

Patrick Lavery
PRAGUE, CZECHIA - NOVEMBER 1, 2019: Astellas logo in front of their main office for Prague. Astellas Pharma is a Japanese Pharmaceutical company spread worldwide | Image Credit: © Jerome - stock.adobe.com
August 28th 2025

Astellas and Pfizer Bladder Cancer Therapy Recommended by UK’s NICE

Patrick Lavery
The front of the REGENXBIO facility in Rockville, Montgomery County, Maryland. REGENXBIO is a biotechnology company researching Adeno-Associate Virus (AAV) gene therapy | Image Credit: © MJ Kerr - stock.adobe.com
August 28th 2025

FDA Extends Review Period for REGENXBIO Hunter Syndrome Treatment

Patrick Lavery
Lung cancer, 3D illustration and photo under microscope. Histopathology light micrograph of small cell lung cancer | Image Credit: © Dr_Microbe - © Dr_Microbe - stock.adobe.com
August 28th 2025

Merck and Daiichi Sankyo’s I-DXd Earns FDA Breakthrough Therapy Status in Small Cell Lung Cancer

Feliza Mirasol
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
August 28th 2025

FDA Grants Breakthrough Therapy Designation to Bispecific ADC for EGFR-Mutant Lung Cancer

Feliza Mirasol
© 2025 MJH Life Sciences

All rights reserved.